Dr. Reddy's [DRREDDY] vs Lupin [LUPIN] Detailed Stock Comparison

Dr. Reddy's

NSE
Loading...

Lupin

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Reddy's wins in 10 metrics, Lupin wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricDr. Reddy'sLupinBetter
P/E Ratio (TTM)18.5923.48Dr. Reddy's
Price-to-Book Ratio2.975.07Dr. Reddy's
Debt-to-Equity Ratio13.7531.50Dr. Reddy's
PEG Ratio9.650.45Lupin
EV/EBITDA11.4316.81Dr. Reddy's
Profit Margin (TTM)16.99%15.83%Dr. Reddy's
Operating Margin (TTM)20.50%23.23%Lupin
EBITDA Margin (TTM)20.50%23.23%Lupin
Return on Equity17.71%18.98%Lupin
Return on Assets (TTM)9.71%11.24%Lupin
Free Cash Flow (TTM)$12.03B$13.18BLupin
Dividend Yield11.59%0.62%Dr. Reddy's
1-Year Return-6.18%-9.87%Dr. Reddy's
Price-to-Sales Ratio (TTM)3.153.73Dr. Reddy's
Enterprise Value$1,021.70B$908.12BDr. Reddy's
EV/Revenue Ratio3.063.89Dr. Reddy's
Gross Profit Margin (TTM)56.91%71.25%Lupin
Revenue per Share (TTM)$401$512Lupin
Earnings per Share (Diluted)$67.16$81.39Lupin
Beta (Stock Volatility)0.330.30Lupin
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dr. Reddy's vs Lupin Stock Performance Analysis

Loading Price Chart...

Dr. Reddy's
Lupin
Dr. Reddy's Stock Overview | Lupin Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Reddy's0.27%-4.11%-2.75%-2.51%8.03%-9.08%
Lupin-0.39%-0.48%4.39%1.04%1.32%-16.22%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Reddy's-6.18%42.20%20.77%46.17%298.84%1,224.71%
Lupin-9.87%174.72%92.51%-3.61%381.48%2,427.49%

News Based Sentiment: Dr. Reddy's vs Lupin

Dr. Reddy's

News based Sentiment: MIXED

Dr. Reddy's reported positive revenue growth in Q1 FY25, but operating profit decreased slightly. Analyst sentiment remains positive with a range of price targets, and the company is maintaining regulatory compliance. The upcoming Q2 FY26 results will be key to understanding the company's trajectory.

View Dr. Reddy's News Sentiment Analysis

Lupin

News based Sentiment: MIXED

September presented a mixed bag for Lupin, with strong financial results and key FDA approvals offset by regulatory observations and market volatility. While the company demonstrates growth potential, ongoing challenges require careful investor monitoring, making it a significant month for the investment story.

View Lupin News Sentiment Analysis

Performance & Financial Health Analysis: Dr. Reddy's vs Lupin

MetricDRREDDYLUPIN
Market Information
Market Cap i₹1.05T₹873.43B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,976,813828,991
90 Day Avg. Volume i1,551,516691,051
Last Close₹1,248.10₹1,973.60
52 Week Range₹1,020.00 - ₹1,405.90₹1,795.20 - ₹2,402.90
% from 52W High-11.22%-17.87%
All-Time High₹1,421.49 (Aug 19, 2024)₹2,402.90 (Dec 30, 2024)
% from All-Time High-12.20%-17.87%
Growth Metrics
Quarterly Revenue Growth0.11%0.12%
Quarterly Earnings Growth0.02%0.52%
Financial Health
Profit Margin (TTM) i0.17%0.16%
Operating Margin (TTM) i0.21%0.23%
Return on Equity (TTM) i0.18%0.19%
Debt to Equity (MRQ) i13.7531.50
Cash & Liquidity
Book Value per Share (MRQ)₹420.56₹376.80
Cash per Share (MRQ)₹80.12₹65.49
Operating Cash Flow (TTM) i₹52.56B₹28.04B
Levered Free Cash Flow (TTM) i₹14.23B₹32.82B
Dividends
Last 12-Month Dividend Yield i11.59%0.62%
Last 12-Month Dividend i₹146.30₹12.00

Valuation & Enterprise Metrics Analysis: Dr. Reddy's vs Lupin

MetricDRREDDYLUPIN
Price Ratios
P/E Ratio (TTM) i18.5923.48
Forward P/E i3.6423.38
PEG Ratio i9.650.45
Price to Sales (TTM) i3.153.73
Price to Book (MRQ) i2.975.07
Market Capitalization
Market Capitalization i₹1.05T₹873.43B
Enterprise Value i₹1.02T₹908.12B
Enterprise Value Metrics
Enterprise to Revenue i3.063.89
Enterprise to EBITDA i11.4316.81
Risk & Other Metrics
Beta i0.330.30
Book Value per Share (MRQ) i₹420.56₹376.80

Financial Statements Comparison: Dr. Reddy's vs Lupin

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DRREDDYLUPIN
Revenue/Sales i₹85.45B₹61.64B
Cost of Goods Sold i₹36.83B₹17.72B
Gross Profit i₹48.63B₹43.92B
Research & Development i₹6.24BN/A
Operating Income (EBIT) i₹16.84B₹32.28B
EBITDA i₹23.41B₹18.81B
Pre-Tax Income i₹19.05B₹14.16B
Income Tax i₹4.95B₹1.94B
Net Income (Profit) i₹14.10B₹12.21B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DRREDDYLUPIN
Cash & Equivalents i₹14.65B₹19.31B
Total Current Assets i₹250.11B₹167.99B
Total Current Liabilities i₹130.39B₹89.61B
Long-Term Debt i₹7.86B₹20.31B
Total Shareholders Equity i₹337.17B₹172.94B
Retained Earnings i₹315.79B₹140.71B
Property, Plant & Equipment i₹0₹84.20M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DRREDDYLUPIN
Operating Cash Flow i₹27.79BN/A
Capital Expenditures i₹-7.67BN/A
Free Cash Flow i₹10.75BN/A
Debt Repayment i₹-253.00MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDRREDDYLUPIN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,976,813828,991
Average Daily Volume (90 Day) i1,551,516691,051
Shares Outstanding i832.00M456.57M
Float Shares i591.38M241.64M
% Held by Insiders i0.29%0.47%
% Held by Institutions i0.52%0.36%

Dividend Analysis & Yield Comparison: Dr. Reddy's vs Lupin

MetricDRREDDYLUPIN
Last 12-Month Dividend i₹146.30₹12.00
Last 12-Month Dividend Yield i11.59%0.62%
3-Year Avg Annual Dividend i₹49.30₹8.00
3-Year Avg Dividend Yield i3.74%0.50%
3-Year Total Dividends i₹147.90₹24.00
Ex-Dividend DateJul 10, 2025Jul 25, 2025